Hydrocarbons, C5, ethylene-manuf.-by-product, hydrogenated

Genetic toxicity: in vitro

Administrative data

Endpoint:

in vitro gene mutation study in bacteria

Remarks:

Type of genotoxicity: gene mutation

Type of information:

migrated information: read-across from supporting substance (structural analogue or surrogate)

Adequacy of study:

key study

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: GLP compliant, guideline study, available as unpublished report, minor restrictions in design and/or reporting but otherwise adequate for assessment.

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

1992

Report date:

1992

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 471 (Bacterial Reverse Mutation Assay)

Deviations:

yes

Remarks:

neither S.typh TA102 nor E. coli WP2 uvrAor E.coli WP2 uvrA (pKM101) were tested.

GLP compliance:

yes

Type of assay:

bacterial reverse mutation assay

Test material

Test material information

Constituent 1

Reference substance name:

Penta-1,3-diene

EC Number:

207-995-2

EC Name:

Penta-1,3-diene

Cas Number:

504-60-9

IUPAC Name:

penta-1,3-diene

Constituent 2

Reference substance name:

1,3-pentadiene

IUPAC Name:

1,3-pentadiene

Constituent 3

Reference substance name:

Piperylene

IUPAC Name:

Piperylene

Details on test material:

- Name of test material (as cited in study report): MRD-91-934
- Physical state: colourless liquid
- Analytical purity: considered 100%
- Lot/batch No.: 1
- Expiration date of the lot/batch: 31 May 1996
- Storage condition of test material: room temperature

Method

Species / strain

Species / strain / cell type:

other: Salmonella typhimurium TA98, TA100, TA1535, TA1537 and TA1538

Metabolic activation:

with and without

Metabolic activation system:

S9 from Arochlor induced rat livers

Test concentrations with justification for top dose:

32, 100, 320, 1000, 3200 µg/plate

Vehicle / solvent:

- Vehicle(s)/solvent(s) used: DMSO

Controls

Controls 1

Negative solvent / vehicle controls:

yes

Remarks:

0.1 mL/plate DMSO

Controls 2

Positive control substance:

other: 2-aminoanthracene (2AA) 5 µg/plate (TA98, TA100, TA1535, TA1537, TA1538 + S9); N-methyl-N-nitro-N-nitrosoguanidine (MNNG) 10 µg/plate (TA100, TA1535 -S9), 9-aminoacridine (9AA) 100 µg/plate (TA1537 -S9); 2-Nitrofluorene (2NF) 5µg/plate (TA98, TA1538 -S9).

Details on test system and experimental conditions:

METHOD OF APPLICATION: in agar (plate incorporation)

DURATION
- Exposure duration: 2 days

NUMBER OF REPLICATIONS: 3

DETERMINATION OF CYTOTOXICITY
- Method: Numbers of revertant colonies per plate counted

Evaluation criteria:

Revertant colonies counted and compared to number of revertant colonies on solvent control plates. Any value that was equal to or greater than three times the mean value of the concurrent vehicle control was considered positive.

Statistics:

Mean plate count and SD for each dose point was determined.

Results and discussion

Test results

Species / strain:

other: TA98, TA100, TA1535, TA1537, TA1538

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

cytotoxicity

Vehicle controls validity:

valid

Positive controls validity:

valid

Remarks on result:

other: all strains/cell types tested

Remarks:

Migrated from field 'Test system'.

Any other information on results incl. tables

In the initial assay neither a positive response nor a dose-related increase in revertants was observed for tester strains TA98, TA100, TA1535 and TA1538. An increase in revertant colonies which was equal to three times vehicle control was noted for TA1537 without metabolic activation at 100 µg/plate. This increase was due to the low mean value of the vehicle control. As the number of revertant colonies was identical to the non treated control this was considered not to be a positive response and was considered not to be biologically significant. Toxicity, either a reduction in the number of revertant colonies or a reduction in the background lawn, was present for all five strains.

 

In a repeat assay, increases were seen for tester strain TA1537 without metabolic activation at 320 µg/plate and with metabolic activation at 32 -1000 µg/plate. These apparent increases were due to the low mean value of the vehicle control. Since all test material dose data produced revertant colony counts that were no greater than the normal range of the vehicle control, these were considered not to be positive responses and were considered not to be of biological significance. A dose-related increase in revertant colonies was not observed for any of the tester strains. Toxicity, either a reduction in the number of revertant colonies or a reduction in the background lawn, was present for all five strains.

Applicant's summary and conclusion

Conclusions:

Interpretation of results (migrated information):
negative with metabolic activation
negative without metabolic activation

MRD-91-934 was negative for genotoxicity in the microbial mutagenesis (Ames) assay. MRD-91-934 did not induce a significant increase in revertant colonies in any of the five tester strains with or without metabolic activation at doses up to and including 3200 µg/plate.

Executive summary:

MRD-91-934 was negative for genotoxicity in the microbial mutagenesis (Ames) assay. MRD-91-934 did not induce a significant increase in revertant colonies in any of the five tester strains with or without metabolic activation at doses up to and including 3200 µg/plate.